Evidence map›Paper›PMID 32717942›Full record

ArticleAntibiotics (Basel, Switzerland)2020

Prescription of Levofloxacin and Moxifloxacin in Select Hospitals in Uganda: A Pilot Study to Assess Guideline Concordance.

Victoria Nambasa, Helen B Ndagije, Allan Serwanga, Leonard Manirakiza, Joanitah Atuhaire, Diana Nakitto, Ronald Kiguba, Albert Figueras

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Victoria NambasaDirectorate of Product Safety, National Drug Authority (NDA), Kampala 23096, Uganda.ORCID 0000-0002-7961-9687
Helen B NdagijeDirectorate of Product Safety, National Drug Authority (NDA), Kampala 23096, Uganda.ORCID 0000-0001-5802-4791
Allan SerwangaDirectorate of Product Safety, National Drug Authority (NDA), Kampala 23096, Uganda.
Leonard ManirakizaDirectorate of Product Safety, National Drug Authority (NDA), Kampala 23096, Uganda.
Joanitah AtuhaireDirectorate of Product Safety, National Drug Authority (NDA), Kampala 23096, Uganda.
Diana NakittoDirectorate of Product Safety, National Drug Authority (NDA), Kampala 23096, Uganda.
Ronald KigubaDepartment of Pharmacology and Therapeutics, Makerere University College of Health Sciences, Kampala 7072, Uganda.
Albert FiguerasDepartament de Farmacologia, Terapèutica i Toxicologia, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.ORCID 0000-0002-2740-2013
Makerere University · UGUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

drug utilization studyfluoroquinolonesmultidrug-resistant tuberculosisprescription habits

Identifiers

PMID32717942
PMCPMC7460426
OpenAlexW3044767989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.